Author
Listed:
- Jennifer Nicole Sims
(Laboratory of Cancer Immunology Target Identification and Validation, Department of Biology, College of Science, Engineering and Technology, Jackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217, USA)
- Barbara Graham
(Laboratory of Cancer Immunology Target Identification and Validation, Department of Biology, College of Science, Engineering and Technology, Jackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217, USA
These authors contributed equally to this work.)
- Maricica Pacurari
(College of Science, Engineering and Technology, Jackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217, USA
These authors contributed equally to this work.)
- Sophia S. Leggett
(Department of Behavioral and Environmental Health, Jackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217, USA)
- Paul B. Tchounwou
(College of Science, Engineering and Technology, Jackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217, USA)
- Kenneth Ndebele
(Laboratory of Cancer Immunology Target Identification and Validation, Department of Biology, College of Science, Engineering and Technology, Jackson State University, 1400 J. R. Lynch Street, Jackson, MS 39217, USA
These authors contributed equally to this work.)
Abstract
Glioblastoma multiforme (GBM) is the most aggressive brain cancer with a median survival of 1–2 years. The treatment of GBM includes surgical resection, radiation and chemotherapy, which minimally extends survival. This poor prognosis necessitates the identification of novel molecular targets associated with glioblastoma. S100P is associated with drug resistance, metastasis, and poor clinical outcomes in many malignancies. The functional role of S100P in glioblastoma has not been fully investigated. In this study, we examined the role of S100P mediating the effects of the environmental contaminant, DEHP, in glioblastoma cells (LN-229) by assessing cell proliferation, apoptosis, anchorage independent growth, cell migration and invasion following DEHP exposure. Silencing S100P and DEHP treatment inhibited LN-229 glioblastoma cell proliferation and induced apoptosis. Anchorage independent growth study revealed significantly decreased colony formation in shS100P cells. We also observed reduced cell migration in cells treated with DEHP following S100P knockdown. Similar results were observed in spheroid formation and expansion. This study is the first to demonstrate the effects of DEHP on glioblastoma cells, and implicates S100P as a potential therapeutic target that may be useful as a drug response biomarker.
Suggested Citation
Jennifer Nicole Sims & Barbara Graham & Maricica Pacurari & Sophia S. Leggett & Paul B. Tchounwou & Kenneth Ndebele, 2014.
"Di-Ethylhexylphthalate (DEHP) Modulates Cell Invasion, Migration and Anchorage Independent Growth through Targeting S100P in LN-229 Glioblastoma Cells,"
IJERPH, MDPI, vol. 11(5), pages 1-14, May.
Handle:
RePEc:gam:jijerp:v:11:y:2014:i:5:p:5006-5019:d:35936
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:11:y:2014:i:5:p:5006-5019:d:35936. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.